Skip to main content
. 2022 Oct 31;76(6):1088–1102. doi: 10.1093/cid/ciac852

Figure 3.

Figure 3.

Multivariable logistic regression for the association between previous SARS-CoV-2 infection and severity of previous COVID-19 disease and (1) development of events of sufficient severity to prevent daily activities or result in work or school absenteeism and/or require a medical consultation (top panels) and (2) events requiring emergency department visit or hospitalization (serious health events) (bottom panels) within 7 days after dose 1, dose 2, and dose 3 vaccination with mRNA-1273. Note: 95% CIs >1 indicate that health events are more likely to occur in individuals with a previous SARS-CoV-2 infection; 95% CIs <1 indicate that events are less likely to occur in individuals with a previous SARS-CoV-2 infection; 95% CIs that cross 1 indicate no association between health-event incidence and previous SARS-CoV-2 infection. The reference group is participants with no previous SARS-CoV-2 infection. Odds ratios are adjusted for age group, sex, health status, province, and experience of health event in dose 1. Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.